BiotechStocks Top Trending on Thursday – January 11, 2018


GT Biopharma Inc. (GTBP) Hits New 2018 High

GT Biopharma (GTBP) has been on our radar for months now and with several key catalysts including a potential Nasdaq Uplisting that could be coming up in the near future, 2018 could be setting up to become a VERY strong year

Click Here For Full Report

Could Big Pharma Use Blockchain Technology To Save More People

That’s the thinking ongoing at pharmaceutical heavyweights Pfizer, Amgen and Sanofi. The three companies – typically black boxes when it comes to their work – are now eyeing blockchain as a means of streamlining the process of developing and testing new drugs. Speaking exclusively to CoinDesk, representatives from the companies shed light on how they are combining efforts to develop a blockchain framework that can address current logjams in the clinical trials process.

Click Here For More Details

Two Power House Companies Are Working on AI-Enabled Immunology

Microsoft and Seattle-based immuno-sequencing company Adaptive Biotechnologies on Jan. 4 announced great news to the public about a collaborative partnership that will bring artificial intelligence to bear on early detection of cancer and other diseases.

Find Out More, Here

An affiliate of BIOTECHSTOCKS,.com MAPH ENTERPRISES LLC., a Florida Corporation that has been compensated $150,000.00 by a GT Biopharma Inc. for a period beginning Jan 1, 2018 and ending Feb. 1, 2018 to publicly disseminate information about (GTBP). We own zero shares. Full Disclaimer


Please enter your name here
Please enter your comment!